• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients

tetano

Editor, Senior Moderator
Clin Infect Dis. 2020 Mar 28. pii: ciaa345. doi: 10.1093/cid/ciaa345. [Epub ahead of print]
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.


Yu F[SUP]1,[/SUP][SUP]2[/SUP], Yan L[SUP]1,[/SUP][SUP]2[/SUP], Wang N[SUP]3,[/SUP][SUP]4[/SUP], Yang S[SUP]1,[/SUP][SUP]2[/SUP], Wang L[SUP]1,[/SUP][SUP]2[/SUP], Tang Y[SUP]1,[/SUP][SUP]2[/SUP], Gao G[SUP]1,[/SUP][SUP]2[/SUP], Wang S[SUP]1,[/SUP][SUP]2[/SUP], Ma C[SUP]1,[/SUP][SUP]2[/SUP], Xie R[SUP]1,[/SUP][SUP]2[/SUP], Wang F[SUP]5[/SUP], Tan C[SUP]5[/SUP], Zhu L[SUP]3[/SUP], Guo Y[SUP]5[/SUP], Zhang F[SUP]1,[/SUP][SUP]2[/SUP].

Author information




Abstract

BACKGROUND:

Coronavirus disease 2019 (COVID-19) has become a public health emergency. The widely used reverse transcription PCR (RT-PCR) method has limitations for clinical diagnosis and treatment.
METHODS:

A total of 323 samples from 76 COVID-19 confirmed patients were analyzed by droplet digital PCR (ddPCR) and RT-PCR based two target genes (ORF1ab and N). Nasal swabs, throat swabs, sputum, blood, and urine were collected. Clinical and imaging data were obtained for clinical staging.
RESULTS:

In 95 samples tested positive by both methods, the cycle threshold (Ct) of RT-PCR was highly correlated with the copy numbed of ddPCR (ORF1ab gene, R2 = 0.83; N gene, R2 = 0.87). 4 (4/161) negative and 41 (41/67) single-gene positive samples tested by RT-PCR were positive according to ddPCR with viral load ranging from 11.1 to 123.2 copies/test. Then the viral load of respiratory samples was compared and the average viral load in sputum (17429 ? 6920 copies/test) was found to be significantly higher than in throat swabs (2552 ? 1965 copies/test, p < 0.001) and nasal swabs (651 ? 501 copies/test, p < 0.001). Furthermore, the viral load in the early and progressive stages were significantly higher than that in the recovery stage (46800 ? 17272 vs 1252 ? 1027, p < 0.001) analyzed by sputum samples.
CONCLUSIONS:

Quantitative monitoring of viral load in lower respiratory tract samples helps to evaluate disease progression, especially in cases of low viral load.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.



KEYWORDS:

COVID-19; RT-PCR; SARS-CoV-2; Viral load; ddPCR


PMID:32221523DOI:10.1093/cid/ciaa345
 
Back
Top